Literature DB >> 33513080

Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia/reperfusion injury.

Aleksandra Stamenkovic1, Kimberley A O'Hara1, David C Nelson1, Thane G Maddaford1, Andrea L Edel1, Graham Maddaford1, Elena Dibrov1, MohamadReza Aghanoori2, Lorrie A Kirshenbaum1, Paul Fernyhough2, Michel Aliani3, Grant N Pierce4, Amir Ravandi5.   

Abstract

Myocardial ischemia/reperfusion (I/R) injury increases the generation of oxidized phosphatidylcholines (OxPCs) which results in cell death. However, the mechanism by which OxPCs mediate cell death is largely unknown. The aim of this study was to determine the mechanisms by which OxPC triggers cardiomyocyte cell death during reperfusion injury. Cardiomyocyte viability, bioenergetic response and calcium transients were determined in the presence of OxPCs. Fragmented OxPCs resulted in a decrease in cell viability with POVPC and PONPC having the most potent cardiotoxic effect in both a concentration and time dependent manner (P<0.05). POVPC and PONPC also caused a significant decrease in Ca2+ transients and net contraction in isolated cardiomyocytes compared to vehicle treated control cells (P<0.05). PONPC depressed maximal respiration rate (p<0.01; 54%) and spare respiratory capacity (p<0.01; 54.5%). Notably, neither caspase 3 activation or TUNEL staining was observed in cells treated with either POVPC or PONPC. Further, cardiac myocytes treated with OxPCs were indistinguishable from vehicle treated control cells with respect to nuclear HMGB1 activity. Glutathione peroxidase 4 activity was markedly suppressed in cardiomyocytes treated with POVPC and PONPC. Importantly, cell death induced by OxPCs could be suppressed E06 Ab, directed against OxPCs or by ferrostatin. The findings of the present study suggest that OxPCs disrupt mitochondrial bioenergetics, calcium transients and provoke wide spread cell death through ferroptosis during I/R. Neutralization of OxPC with E06 or with ferrostatin-1 prevents cell death during reperfusion. Our study demonstrates a novel signaling pathway that operationally links generation of OxPC during cardiac I/R to ferroptosis.

Entities:  

Keywords:  ferroptosis; phospholipids; reperfusion

Year:  2021        PMID: 33513080     DOI: 10.1152/ajpheart.00237.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  16 in total

1.  HMOX1 silencing prevents doxorubicin-induced cardiomyocyte injury, mitochondrial dysfunction, and ferroptosis by downregulating CTGF.

Authors:  Jia Qian; Wenting Wan; Min Fan
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-08-25

Review 2.  Roles of Ferroptosis in Cardiovascular Diseases.

Authors:  Yuting Guo; Wei Zhang; Xinger Zhou; Shihao Zhao; Jian Wang; Yi Guo; Yichao Liao; Haihui Lu; Jie Liu; Yanbin Cai; Jiao Wu; Mingzhi Shen
Journal:  Front Cardiovasc Med       Date:  2022-05-23

Review 3.  The Role of Ferroptosis in Adverse Left Ventricular Remodeling Following Acute Myocardial Infarction.

Authors:  Kyoko Komai; Nicholas K Kawasaki; Jason K Higa; Takashi Matsui
Journal:  Cells       Date:  2022-04-20       Impact factor: 7.666

Review 4.  Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury.

Authors:  José Lillo-Moya; Catalina Rojas-Solé; Diego Muñoz-Salamanca; Emiliano Panieri; Luciano Saso; Ramón Rodrigo
Journal:  Antioxidants (Basel)       Date:  2021-04-25

5.  DGAT1 activity synchronises with mitophagy to protect cells from metabolic rewiring by iron  depletion.

Authors:  Maeve Long; Alvaro Sanchez-Martinez; Marianna Longo; Fumi Suomi; Hans Stenlund; Annika I Johansson; Homa Ehsan; Veijo T Salo; Lambert Montava-Garriga; Seyedehshima Naddafi; Elina Ikonen; Ian G Ganley; Alexander J Whitworth; Thomas G McWilliams
Journal:  EMBO J       Date:  2022-04-12       Impact factor: 14.012

6.  Structural library and visualization of endogenously oxidized phosphatidylcholines using mass spectrometry-based techniques.

Authors:  Yuta Matsuoka; Masatomo Takahashi; Yuki Sugiura; Yoshihiro Izumi; Kazuhiro Nishiyama; Motohiro Nishida; Makoto Suematsu; Takeshi Bamba; Ken-Ichi Yamada
Journal:  Nat Commun       Date:  2021-11-03       Impact factor: 14.919

7.  Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI).

Authors:  Zahra Solati; Arun Surendran; Andrea Edel; Marynia Roznik; David Allen; Amir Ravandi
Journal:  Front Med (Lausanne)       Date:  2021-12-01

8.  Gossypol Acetic Acid Attenuates Cardiac Ischemia/Reperfusion Injury in Rats via an Antiferroptotic Mechanism.

Authors:  Jian-Hong Lin; Kun-Ta Yang; Pei-Ching Ting; Yu-Po Luo; Ding-Jyun Lin; Yi-Shun Wang; Jui-Chih Chang
Journal:  Biomolecules       Date:  2021-11-10

Review 9.  Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury.

Authors:  Xinye Li; Ning Ma; Juping Xu; Yanchi Zhang; Pan Yang; Xin Su; Yanfeng Xing; Na An; Fan Yang; Guoxia Zhang; Lijing Zhang; Yanwei Xing
Journal:  Oxid Med Cell Longev       Date:  2021-10-28       Impact factor: 6.543

Review 10.  Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury.

Authors:  Wei-Kun Zhao; Yao Zhou; Tong-Tong Xu; Qi Wu
Journal:  Oxid Med Cell Longev       Date:  2021-10-23       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.